A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL
Autor: | Christophe Blockeel, Xin Chen, Ling Deng, Shi-Ling Chen, De-Sheng Ye, Xue-Lan Li, Xing-Yu Zhou |
---|---|
Přispěvatelé: | Surgical clinical sciences, Reproduction and Genetics, Centre for Reproductive Medicine - Gynaecology |
Rok vydání: | 2019 |
Předmět: |
Adult
Agonist medicine.medical_specialty Pregnancy Rate medicine.drug_class medicine.medical_treatment Oocyte Retrieval Ovarian hyperstimulation syndrome Fertilization in Vitro Luteal phase freeze-all Biochemistry Gonadotropin-Releasing Hormone Ovarian Hyperstimulation Syndrome Bolus (medicine) Ovarian Follicle Ovulation Induction Pregnancy Internal medicine GnRH antagonist Genetics medicine Humans GnRH agonist In vitro fertilisation Estradiol business.industry Fertility Agents Female Oocyte medicine.disease Regimen Endocrinology medicine.anatomical_structure in-vitro fertilization Female business Infertility Female Hormone |
Zdroj: | Current Medical Science. 39:278-284 |
ISSN: | 2523-899X 2096-5230 |
Popis: | This observational study included 21 patients at remarkably high risk of ovarian hyperstimulation syndrome (OHSS), characterized by more than 30 follicles measuring ≥11 mm in diameter on trigger day and/or pre-trigger peak estradiol exceeding 10 000 pg/mL, which was also the feature of women with established severe early OHSS followed by gonadotrophin-releasing hormone agonist (GnRHa) trigger and freeze-all policy that previously have been reported. All patients received a second dose of GnRHa 12 h after the first GnRHa trigger combined with administration of GnRH antagonist at 0.25 mg/day for a period of 3 days from the day of oocyte retrieval onwards. The in vitro fertilization (IVF) outcomes may be preferable compared with a bolus of GnRHa trigger and none of the included patients developed moderate-to-severe OHSS. Moreover, patients' symptoms, reproductive hormone levels and ultrasound findings were improved significantly. This new strategy seems to be efficacious and could be a further supplement of GnRHa trigger with or without applying freeze-all strategy to completely prevent early-onset moderate to severe OHSS, especially for the patients characterized by ≤30 follicles measuring ≥11 mm in diameter on trigger day and/or pre-trigger peak estradiol exceeding 10 000 pg/mL. Further studies should be performed to compare this regimen with conventional methods of OHSS prevention. |
Databáze: | OpenAIRE |
Externí odkaz: |